In the United States, 5F-MDMB-PICA was temporarily emergency scheduled by the DEA in 2019.[10] In December 2019, the
UNODC announced scheduling recommendations placing 5F-MDMB-PICA into Schedule II.[11] In the United States 5F-MDMB-PICA was made a permanent
Schedule I Controlled Substance nationwide on April 7, 2022.[12]
^Pulver B, Fischmann S, Gallegos A, Christie R (March 2023). "EMCDDA framework and practical guidance for naming synthetic cannabinoids". Drug Testing and Analysis. 15 (3): 255–276.
doi:
10.1002/dta.3403.
PMID36346325.
S2CID253396419.
^Szpot P, Nowak K, Wachełko O, Tusiewicz K, Chłopaś-Konowałek A, Zawadzki M (January 2023). "Methyl (S)-2-(1-7 (5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (5F-MDMB-PICA) intoxication in a child with identification of two new metabolites (ultra-high-performance liquid chromatography-tandem mass spectrometry)". Forensic Toxicology. 41 (1): 47–58.
doi:
10.1007/s11419-022-00629-7.
PMID36652054.
S2CID249318941.
^Banister SD, Longworth M, Kevin R, Sachdev S, Santiago M, Stuart J, et al. (September 2016). "Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues". ACS Chemical Neuroscience. 7 (9): 1241–1254.
doi:
10.1021/acschemneuro.6b00137.
PMID27421060.
In the United States, 5F-MDMB-PICA was temporarily emergency scheduled by the DEA in 2019.[10] In December 2019, the
UNODC announced scheduling recommendations placing 5F-MDMB-PICA into Schedule II.[11] In the United States 5F-MDMB-PICA was made a permanent
Schedule I Controlled Substance nationwide on April 7, 2022.[12]
^Pulver B, Fischmann S, Gallegos A, Christie R (March 2023). "EMCDDA framework and practical guidance for naming synthetic cannabinoids". Drug Testing and Analysis. 15 (3): 255–276.
doi:
10.1002/dta.3403.
PMID36346325.
S2CID253396419.
^Szpot P, Nowak K, Wachełko O, Tusiewicz K, Chłopaś-Konowałek A, Zawadzki M (January 2023). "Methyl (S)-2-(1-7 (5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (5F-MDMB-PICA) intoxication in a child with identification of two new metabolites (ultra-high-performance liquid chromatography-tandem mass spectrometry)". Forensic Toxicology. 41 (1): 47–58.
doi:
10.1007/s11419-022-00629-7.
PMID36652054.
S2CID249318941.
^Banister SD, Longworth M, Kevin R, Sachdev S, Santiago M, Stuart J, et al. (September 2016). "Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues". ACS Chemical Neuroscience. 7 (9): 1241–1254.
doi:
10.1021/acschemneuro.6b00137.
PMID27421060.